Treatment of the Diabetic Heart Failure Patient

Published: 01 July 2020

  • Views:

    Views Icon 44

  • Likes:

    Heart Icon 7
Average (ratings)
No ratings
Your rating

Overview

Prof Mark Petrie (University of Glasgow, Glasgow, UK) joins Dr Mikhail N Kosiborod (Saint Luke's Mid America Heart Institute, Kansas City, US) to discuss heart failure in patients with diabetes with consideration to new data emerging from SGLT2 inhibitors and GLP-1 Receptor Agonists.

This discussion was supported by an unrestricted educational grant from Novo Nordisk

More from this programme

Part 1

Diabetes and Heart Failure Outcomes

Prof Mark Petrie (University of Glasgow, Glasgow, UK) joins Dr Mikhail N Kosiborod (Saint Luke's Mid America Heart Institute, Kansas City, US) to discuss heart failure in patients with diabetes.
1 session
Diabetes and Heart Failure Outcomes Watch now

Part 2

SGLT2 Inhibitors in Heart Failure

Prof Mark Petrie (University of Glasgow, Glasgow, UK) joins Dr Mikhail N Kosiborod (Saint Luke's Mid America Heart Institute, Kansas City, US) to discuss heart failure in patients with diabetes.
1 session
SGLT2 Inhibitors in Heart Failure Watch now

Part 3

GLP-1 Receptor Agonists in Heart Failure

Prof Mark Petrie (University of Glasgow, Glasgow, UK) joins Dr Mikhail N Kosiborod (Saint Luke's Mid America Heart Institute, Kansas City, US) to discuss the potential benefits of glucagon-like peptide 1 (GLP1) receptor agonists for patients with heart failure. They summarise trials that looked into novel antidiabetic agents to date (FIGHT, HARMONY and LIVE). Dr Kosiborod reviews the latest guidelines reflecting on the data. Prof Petrie outlines the potential mechanism behind the benefits of GLP1 receptor agonists in MACE-like events. They discusses the role of novel antidiabetic agents in the treatment of heart failure with preserved ejection fraction and heart failure with reduced ejection fraction.
1 session
GLP-1 Receptor Agonists in Heart Failure Watch now

Faculty Biographies

Mikhail Kosiborod

Mikhail Kosiborod

Cardiologist

Dr Kosiborod is an internationally recognised expert in the fields of diabetes and cardiovascular disease, cardiometabolic and cardiorenal syndromes, and quality care and outcomes.

View full profile
Mark Petrie

Mark Petrie

Professor/Honorary Consultant (Institute of Cardiovascular & Medical Sciences)

Professor Mark Petrie worked as an interventional cardiologist before his professorship at University of Glasgow. His interests include revascularization in heart failure, diabetes and cardiovascular disease and cardio-oncology. 

View full profile